市場調査レポート

不妊症治療薬・装置市場 - 世界的産業分析、市場規模、シェア、成長率および将来予測

Infertility Drugs And Devices Market - Global Industry Analysis, Size, Share And Forecast, 2010 - 2017

発行 Transparency Market Research 商品コード 252175
出版日 ページ情報 英文 130 Pages
納期: 即日から翌営業日
価格
こちらの商品の販売は終了いたしました。
Back to Top
不妊症治療薬・装置市場 - 世界的産業分析、市場規模、シェア、成長率および将来予測 Infertility Drugs And Devices Market - Global Industry Analysis, Size, Share And Forecast, 2010 - 2017
出版日: 2012年11月17日 ページ情報: 英文 130 Pages

当商品の販売は、2016年07月20日を持ちまして終了しました。

概要

当レポートでは、今後数年間を対象に、世界の不妊症治療薬・装置市場およびその裾野産業を支える原動力を考察すべく、参入企業のプロフィールをはじめ、産業状況、現行市場トレンド、市場の推進要因および課題などを分析・予測する最新の調査情報をまとめ、概略以下の構成でお届けします。

第1章 序

  • 要旨
  • レポート内容
  • 調査方法

第2章 エグゼクティブサマリーおよび市場概要

第3章 不妊症治療薬・装置市場分析

  • 世界不妊症治療薬・装置市場の収益額および年間成長率
    • 2010年および2017年市場比較分析
    • 不妊症治療薬市場収益額
    • 不妊症治療装置市場収益額
  • 人口成長傾向
    • 世界の男女人口成長傾向 - 年齢層別
    • 不妊症治療薬・装置市場求心力分析 - 地域別
  • 不妊の原因
  • 市場動態
    • 推進要因
    • 妊症治療薬・装置市場推進要因の影響分析
    • 抑制要因
    • 機会
  • 市場シェア分析 - 2011年
  • 不妊症治療薬・装置市場に対するPorterのファイブフォース分析

第4章 不妊症治療薬・装置市場セグメンテーション

  • 世界の不妊治療薬・装置市場 - タイプ別
    • 女性不妊症患者人口 - タイプ別
      • 子宮内膜症
      • 卵巣障害
      • 子宮障害
      • 卵管障害
      • ホルモン障害
    • 男性不妊症患者人口 - タイプ別
      • 無精子症
      • 精索静脈瘤
      • 射精障害
      • 勃起不全
  • 不妊治療薬・装置市場 - 技術別
    • 世界の不妊治療薬・装置市場 - 人工授精
    • 世界の不妊治療薬・装置市場 - 生殖介助技術
    • 世界の不妊治療薬・装置市場 - 体外受精
    • 世界の不妊治療薬・装置市場 - 外科手術

第5章 地域分析

  • 不妊治療薬・装置市場 - 地域別
  • 欧州
    • 英国
    • フランス
    • ドイツ
    • イタリア
    • スペイン
  • 北米
    • 米国
    • カナダ
    • メキシコ
  • アジア太平洋州
    • 日本
    • インド
    • 中国
  • その他の地域(ROW)
    • ブラジル

第6章 企業プロフィール

  • JOHNSON & JOHNSON
    • 企業概要
    • 財務概要
    • 事業戦略
    • 最新展開
  • MERCK
  • TEVA PHARMACEUTICALS
  • ORIGIO
  • BAYER
目次

This report is an effort to identify factors, which will be the driving force for the infertility drugs and devices market and sub-markets in the next few years. The report provides an extensive analysis of the industry, current market trends, industry drivers and challenges for better understanding of the market structure. The report segregates the infertility drugs and devices industry in terms of products, technology and geography. We have used a combination of primary and secondary research to arrive at the market estimates, market shares and trends. We have adopted bottom up model to derive market size of the global infertility drugs and devices market and further validated numbers with the key market participants and C-level executives.

This report highlights the industry with the following points:

  • Definition, estimates and forecast of infertility drugs and devices market from 2010 to 2017
  • Analysis of product segments for infertility drugs and devices market with historical data and forecast
  • Trends and forecast for four geographic markets, namely North America, Europe, Asia Pacific and the RoW regions based on segments of infertility drugs and devices market
  • Profiles of major market participants for better understanding of their contributions
  • This research is specially designed to estimate and analyze the demand and performance of infertility drugs and devices in a global scenario. The research provides in-depth analysis of infertility drugs and devices manufacturers, product sales, trend analysis by segments and demand by geography. The report covers all the major product segments of the global infertility drugs and devices market and provide in-depth analysis, historical data and statistically refined forecast for the segments covered. The study presents a comprehensive assessment of the stakeholder strategies and winning imperatives for them by segmenting the global infertility drugs and devices market as below:

Infertility Drugs and Devices Market by Types

Female

  • Endometriosis
  • Ovarian Disorders
  • Uterine Disorders
  • Tubal Disorders
  • Hormonal Disorders

Male

  • Azoospermia
  • Varicocele
  • Ejaculation Disorder
  • Erectile Dysfunction

Infertility Drugs and Devices by Technology

  • Assisted Reproductive Technologies
  • In Vitro Fertilization
  • Artificial Insemination
  • Surgery

Infertility Drugs and Devices Market by Geography

Europe Infertility Drugs and Devices Market

  • U.K
  • France
  • Germany
  • Italy
  • Spain

North America Infertility Drugs And Devices Market

  • U.S
  • Canada
  • Mexico

Asia Pacific Infertility Drugs And Devices Market

  • Japan
  • India
  • China

Row Infertility Drugs And Devices Market

  • Brazil's

The in-depth research and high level analysis will allow infertility drugs and device manufacturers, lawmakers, large retailers, medical companies and research and development agencies to make informed decisions about infertility drugs and devices manufacturing, designing marketing, growth strategies and gaining competitive advantage.

Table of Contents

CHAPTER 1 - PREFACE

  • 1.1 KEY POINTS COVERED
  • 1.2 REPORT DESCRIPTION
  • 1.3 RESEARCH METHODOLOGY

CHAPTER 2 - EXECUTIVE SUMMARY AND MARKET OVERVIEW

CHAPTER 3 - INFERTILITY DRUGS AND DEVICES MARKET ANALYSIS

  • 3.1. GLOBAL INFERTILITY DRUGS AND DEVICES MARKET REVENUE (USD THOUSAND) AND ANNUAL GROWTH RATE, 2010 - 2017
    • 3.1.1. COMPARATIVE ANALYSIS OF GLOBAL INFERTILITY DRUGS AND DEVICES MARKET, 2010 V/S 2017
    • 3.1.2. GLOBAL INFERTILITY DRUGS MARKET REVENUE, 2010 - 2017
    • GLOBAL INFERTILITY DEVICES MARKET REVENUE, 2010 - 2017
  • 3.2. POPULATION GROWTH TREND
    • 3.2.1. GLOBAL MALE AND FEMALE POPULATION GROWTH TREND BY AGE GROUP
    • 3.2.2. INFERTILITY DRUGS AND DEVICES MARKET ATTRACTIVENESS ANALYSIS BY GEOGRAPHY
  • 3.3. CAUSES OF INFERTILITY
  • 3.4. MARKET DYNAMICS
    • 3.4.1. DRIVERS
      • 3.4.1.1. Rising number of infertile people
      • 3.4.1.2. Increasing worldwide obesity
      • 3.4.1.3. Rising disposable incomes of the consumers
      • 3.4.1.4. Lifestyle hazards such as rising number of smokers, stress and pollution
      • 3.4.1.5. Adoption of babies by homosexual couples
      • 3.4.1.6. Availability of government support for infertility abatement procedures
    • 3.4.2. INFERTILITY DRUGS AND DEVICES MARKET DRIVER IMPACT ANALYSIS
    • 3.4.3. RESTRAINTS
      • 3.4.3.1. Limited insurance covers
      • 3.4.3.2. Religious bans on artificial insemination procedures especially the Islamic bans
      • 3.4.3.3. Risk of repeat procedures
      • 3.4.3.4. Traditional infertility treatments such as the Chinese infertility treatments
      • 3.4.3.5. Ban on artificial reproduction procedures in European countries especially Turkey, Germany, Italy and France
      • 3.4.3.6. Patent expiration of infertility drugs
    • 3.4.4. INFERTILITY DRUGS AND DEVICES MARKET RESTRAINTS IMPACT ANALYSIS
    • 3.4.5. OPPORTUNITY
      • 3.4.5.1. Technological advancements in the Asia Pacific region and the developmental activities in the region
      • 3.4.5.2. Medical tourism initiatives in the developing countries
      • 3.4.5.3. Need for more ART cycles
  • 3.1. MARKET SHARE ANALYSIS, 2011
  • 3.2. PORTER'S FIVE FORCES ANALYSIS FOR THE INFERTILITY DRUGS AND DEVICES MARKET
    • 3.2.1. BARGAINING POWER OF SUPPLIERS
    • 3.2.1. BARGAINING POWER OF BUYERS
    • 3.2.2. THREAT OF NEW ENTRANTS
    • 3.2.3. THREAT OF SUBSTITUTES
    • 3.2.4. COMPETITIVE RIVALRY

CHAPTER 4 - INFERTILITY DRUGS AND DEVICES MARKET SEGMENTATION

  • 4.1. GLOBAL INFERTILITY DRUGS AND DEVICES MARKET BY TYPES
    • 4.1.1. FEMALE INFERTILITY POPULATION PREVALENCE BY TYPES
      • 4.1.1.1. Global Infertility drugs and devices market by Endometriosis female infertility types
      • 4.1.1.2. Global Infertility drugs and devices market by Ovarian disorder female infertility types
      • 4.1.1.3. Global Infertility drugs and devices market by Uterine disorder female infertility types
      • 4.1.1.4. Global Infertility drugs and devices market by Tubal disorder female infertility types
      • 4.1.1.5. Global Infertility drugs and devices market by Hormonal disorder female infertility types
    • 4.1.2. MALE INFERTILITY POPULATION PREVALENCE BY TYPES
      • 4.1.2.1. Global Infertility drugs and devices market by Azoospermia male infertility types
      • 4.1.2.2. Global Infertility drugs and devices market by Varicocele male infertility types
      • 4.1.2.3. Global Infertility drugs and devices market by Ejaculation Disorder male infertility types
      • 4.1.2.4. Global Infertility drugs and devices market by Erectile Dysfunction male infertility types
  • 4.2. INFERTILITY DRUGS AND DEVICES MARKET BY TECHNOLOGY
    • 4.2.1. GLOBAL INFERTILITY DRUGS AND DEVICES MARKET BY ARTIFICIAL INSEMINATION
    • 4.2.2. GLOBAL INFERTILITY DRUGS AND DEVICES MARKET BY ASSISTED REPRODUCTIVE TECHNOLOGIES (USD THOUSAND)
    • 4.2.3. GLOBAL INFERTILITY DRUGS AND DEVICES MARKET BY IN VITRO FERTILIZATION (USD THOUSAND)
    • 4.2.4. GLOBAL INFERTILITY DRUGS AND DEVICES MARKET BY SURGERY (USD THOUSAND) 57

CHAPTER 5 - REGION-WISE ANALYSIS

  • 5.1. INFERTILITY DRUGS AND DEVICES MARKET BY REGION
    • 5.1.1. EUROPE INFERTILITY DRUGS AND DEVICES MARKET
      • 5.1.1.1. U.K
      • 5.1.1.2. France
      • 5.1.1.3. Germany
      • 5.1.1.4. Italy
      • 5.1.1.5. Spain
    • 5.1.2. NORTH AMERICA INFERTILITY DRUGS AND DEVICES MARKET
    • 5.1.3. NORTH AMERICA INFERTILITY DRUGS AND DEVICES MARKET
      • 5.1.3.1. U.S
      • 5.1.3.2. CANADA
      • 5.1.3.3. MEXICO
    • 5.1.4. ASIA PACIFIC INFERTILITY DRUGS AND DEVICES MARKET
    • 5.1.5. ASIA PACIFIC INFERTILITY DRUGS AND DEVICES MARKET
      • 5.1.5.1. Japan
      • 5.1.5.2. India
      • 5.1.5.3. China
    • 5.1.6. ROW INFERTILITY DRUGS AND DEVICES MARKET
    • 5.1.7. ROW INFERTILITY DRUGS AND DEVICES MARKET
      • 5.1.7.1. Brazil's Infertility drugs and devices market

CHAPTER 6 - COMPANY PROFILES

  • 6.1. JOHNSON & JOHNSON
    • 6.1.1. COMPANY OVERVIEW
    • 6.1.2. FINANCIAL OVERVIEW
    • 6.1.3. BUSINESS STRATEGIES
    • 6.1.4. RECENT DEVELOPMENTS
  • 6.2. MERCK
    • 6.2.1. COMPANY OVERVIEW
    • 6.2.2. FINANCIAL OVERVIEW
    • 6.2.3. BUSINESS STRATEGIES
    • 6.2.4. PRODUCT PORTFOLIO
    • 6.2.5. RECENT DEVELOPMENT
  • 6.3. TEVA PHARMACEUTICALS
    • 6.3.1. COMPANY OVERVIEW
    • 6.3.2. FINANCIAL OVERVIEW
    • 6.3.3. BUSINESS STRATEGIES
    • 6.3.4. PRODUCT PORTFOLIO
    • 6.3.5. RECENT DEVELOPMENTS
  • 6.4. ORIGIO
    • 6.4.1. COMPANY OVERVIEW
    • 6.4.2. FINANCIAL OVERVIEW
    • 6.4.3. BUSINESS STRATEGIES
    • 6.4.4. PRODUCT PORTFOLIO
    • 6.4.5. RECENT DEVELOPMENTS
  • 6.5. BAYER
    • 6.5.1. COMPANY OVERVIEW
    • 6.5.2. FINANCIAL OVERVIEW
    • 6.5.3. BUSINESS STRATEGIES
    • 6.5.4. PRODUCT PORTFOLIO
    • 6.5.5. RECENT DEVELOPMENT

LIST OF FIGURES

  • FIG. 1: GLOBAL INFERTILITY DRUGS AND DEVICES MARKET REVENUE (USD THOUSAND) AND ANNUAL GROWTH RATE, 2010 - 2017 (%)
  • FIG. 2: COMPARATIVE ANALYSIS OF GLOBAL INFERTILITY DRUGS AND DEVICES MARKET SHARE, 2010 VS 2017
  • FIG. 3: GLOBAL INFERTILITY DRUGS MARKET REVENUE, 2010 - 2017 (USD THOUSAND), ANNUAL GROWTH RATE, 2010 - 2017 (%)
  • FIG. 4: GLOBAL POPULATION TREND, MALE AND FEMALE POPULATION TREND, 2010 - 2017 (THOUSANDS)
  • FIG. 5: GLOBAL FERTILE MALE AND FEMALE POPULATION TREND, 2010 - 2017 (THOUSANDS)
  • FIG. 6: GLOBAL INFERTILITY DEVICES MARKET REVENUE, 2010 - 2017 (USD THOUSAND), ANNUAL GROWTH RATE, 2010 - 2017 (%)
  • FIG. 7: MARKET ATTRACTIVENESS - INFERTILITY DRUGS AND DEVICES MARKET BY GEOGRAPHY
  • FIG. 8: CAUSES OF INFERTILITY
  • FIG. 9: PORTER'S FIVE FORCES ANALYSIS FOR THE INFERTILITY DRUGS AND DEVICES MARKET
  • FIG. 10: COMPARITIVE ANALYSIS OF INFERTILITY DRUGS AND DEVICES MARKET SHARE BY GEOGRAPHY, 2010 AND 2017 (%)
  • FIG. 11: EUROPE INFERTILITY DRUGS AND DEVICES MARKET, 2010 - 2017 (USD THOUSAND), ANNUAL GROWTH RATE, 2010 - 2017 (%)
  • FIG. 12: NORTH AMERICA INFERTILITY DRUGS AND DEVICES MARKET, 2010 - 2017 (USD THOUSAND), ANNUAL GROWTH RATE, 2010 - 2017 (%)
  • FIG. 13: ASIA PACIFIC INFERTILITY DRUGS AND DEVICES MARKET, 2010 - 2017 (USD THOUSAND), ANNUAL GROWTH RATE, 2010 - 2017 (%)
  • FIG. 14: DECLINING FERTILITY RATE IN JAPAN, 2007 - 2011
  • FIG. 15: ROW INFERTILITY INFERTILITY DRUGS AND DEVICES MARKET, 2010 - 2017 (USD THOUSAND), ANNUAL GROWTH RATE, 2010 - 2017 (%)
  • FIG. 16: JOHNSON & JOHNSON'S ANNUAL SALES, 2007 - 2011 (USD MILLION), ANNUAL GROWTH RATE, 2007 - 2010 (%)
  • FIG. 17: MERCK'S ANNUAL REVENUE, 2007 - 2011 (USD MILLION), ANNUAL GROWTH RATE, 2007 - 2010 (%)
  • FIG. 18: TEVA PHARMACEUTICAL'S ANNUAL REVENUE, 2007 - 2011 (USD MILLION), ANNUAL GROWTH RATE, 2007 - 2010 (%)
  • FIG. 19: ORIGIO'S ANNUAL REVENUE, 2010 - 2011 (USD MILLION)
  • FIG. 20: BAYER'S ANNUAL SALES, 2010 - 2011 (USD MILLION)

LIST OF TABLES

  • TABLE 1: IMPACT ANALYSIS OF DRIVERS
  • TABLE 2: IMPACT ANALYSIS OF RESTRAINTS
  • TABLE 3: GLOBAL FEMALE INFERTILITY POPULATION PREVALENCE, 2010 - 2017 (THOUSAND )
  • TABLE 4: GLOBAL MALE INFERTILITY POPULATION PREVALENCE, 2010 - 2017 (THOUSAND )
  • TABLE 5: GLOBAL INFERTILITY DRUGS AND DEVICES MARKET BY ARTIFICIAL INSEMINATION TECHNOLOGY, 2010 - 2017 (USD THOUSAND)
  • TABLE 6: U.K INFERTILITY DRUGS AND DEVICES MARKET, 2010 - 2017 (USD THOUSAND)
  • TABLE 7: U.K POPULATION BY DEMOGRAPHICS, 2010 - 2017 (THOUSAND)
  • TABLE 8: U.K MALE INFERTILITY POPULATION PREVALENCE, 2010 - 2017 (THOUSAND)
  • TABLE 9: U.K FEMALE INFERTILITY POPULATION PREVALENCE, 2010 - 2017 (THOUSAND )
  • TABLE 10: U.K INFERTILITY DRUGS AND DEVICES TECHNOLOGY MARKET REVENUE BY FERTILITY TYPE, 2010 - 2017 (USD THOUSAND )
  • TABLE 11: U.K INFERTILITY DRUGS AND DEVICES MARKET BY ARTIFICIAL INSEMINATION TECHNOLOGY, 2010 - 2017 (USD THOUSAND )
  • TABLE 12: FRANCE INFERTILITY DRUGS AND DEVICES MARKET, 2010 - 2017 (USD THOUSAND)
  • TABLE 13: FRANCE POPULATION BY DEMOGRAPHICS, 2010 - 2017 (THOUSAND)
  • TABLE 14: FRANCE MALE INFERTILITY POPULATION PREVALENCE, 2010 - 2017 (THOUSAND)
  • TABLE 15: FRANCE FEMALE INFERTILITY POPULATION PREVALENCE, 2010 - 2017 (THOUSAND )
  • TABLE 16: FRANCE INFERTILITY DRUGS AND DEVICES TECHNOLOGY MARKET REVENUE BY FERTILITY TYPE, 2010 - 2017 (USD THOUSAND )
  • TABLE 17: FRANCE INFERTILITY DRUGS AND DEVICES MARKET BY ARTIFICIAL INSEMINATION TECHNOLOGY, 2010 - 2017 (USD THOUSAND )
  • TABLE 18: GERMANY INFERTILITY DRUGS AND DEVICES MARKET, 2010 - 2017 (USD THOUSAND)
  • TABLE 19: GERMANY POPULATION BY DEMOGRAPHICS, 2010 - 2017 (THOUSAND)
  • TABLE 20: GERMANY MALE INFERTILITY POPULATION PREVALENCE, 2010 - 2017 (THOUSAND)
  • TABLE 21: GERMANY FEMALE INFERTILITY POPULATION PREVALENCE, 2010 - 2017 (THOUSAND )
  • TABLE 22: GERMANY INFERTILITY DRUGS AND DEVICES TECHNOLOGY MARKET REVENUE BY FERTILITY TYPE, 2010 - 2017 (USD THOUSAND
  • TABLE 23: GERMANY INFERTILITY DRUGS AND DEVICES MARKET BY ARTIFICIAL INSEMINATION TECHNOLOGY, 2010 - 2017 (USD THOUSAND )
  • TABLE 24: ITALY INFERTILITY DRUGS AND DEVICES MARKET, 2010 - 2017 (USD THOUSAND)
  • TABLE 25: ITALY POPULATION BY DEMOGRAPHICS, 2010 - 2017 (THOUSAND)
  • TABLE 26: ITALY MALE INFERTILITY POPULATION PREVALENCE, 2010 - 2017 (THOUSAND)
  • TABLE 27: ITALY FEMALE INFERTILITY POPULATION PREVALENCE, 2010 - 2017 (THOUSAND )
  • TABLE 28: ITALY INFERTILITY DRUGS AND DEVICES TECHNOLOGY MARKET REVENUE BY FERTILITY TYPE, 2010 - 2017 (USD THOUSAND )
  • TABLE 29: ITALY INFERTILITY DRUGS AND DEVICES MARKET BY ARTIFICIAL INSEMINATION TECHNOLOGY, 2010 - 2017 (USD THOUSAND )
  • TABLE 30: SPAIN INFERTILITY DRUGS AND DEVICES MARKET, 2010 - 2017 (USD THOUSAND)
  • TABLE 31: SPAIN POPULATION BY DEMOGRAPHICS, 2010 - 2017 (THOUSAND)
  • TABLE 32: SPAIN MALE INFERTILITY POPULATION PREVALENCE, 2010 - 2017 (THOUSAND)
  • TABLE 33: SPAIN FEMALE INFERTILITY POPULATION PREVALENCE, 2010 - 2017 (THOUSAND )
  • TABLE 34: SPAIN INFERTILITY DRUGS AND DEVICES TECHNOLOGY MARKET REVENUE BY FERTILITY TYPE, 2010 - 2017 (USD THOUSAND )
  • TABLE 35: SPAIN INFERTILITY DRUGS AND DEVICES MARKET BY ARTIFICIAL INSEMINATION TECHNOLOGY, 2010 - 2017 (USD THOUSAND )
  • TABLE 36: U.S INFERTILITY DRUGS AND DEVICES MARKET, 2010 - 2017 (USD THOUSAND)
  • TABLE 37: U.S POPULATION BY DEMOGRAPHICS, 2010 - 2017 (THOUSAND)
  • TABLE 38: U.S MALE INFERTILITY POPULATION PREVALENCE, 2010 - 2017 (THOUSAND)
  • TABLE 39: U.S MALE INFERTILITY POPULATION TREATED, 2010 - 2017 (THOUSAND)
  • TABLE 40: U.S FEMALE INFERTILITY POPULATION PREVALENCE, 2010 - 2017 (THOUSAND)
  • TABLE 41: U.S INFERTILITY DRUGS AND DEVICES TECHNOLOGY MARKET REVENUE BY FERTILITY TYPE, 2010 - 2017 (USD THOUSAND )
  • TABLE 42: U.S INFERTILITY DRUGS AND DEVICES MARKET BY ARTIFICIAL INSEMINATION TECHNOLOGY, 2010 - 2017 (USD THOUSAND)
  • TABLE 43: CANADA INFERTILITY DRUGS AND DEVICES MARKET, 2010 - 2017 (USD THOUSAND)
  • TABLE 44: CANADA POPULATION BY DEMOGRAPHICS, 2010 - 2017 (THOUSAND)
  • TABLE 45: CANADA MALE INFERTILITY POPULATION PREVALENCE 2010 - 2017 (THOUSAND)
  • TABLE 46: CANADA FEMALE INFERTILITY POPULATION PREVALENCE, 2010 - 2017 (THOUSAND)
  • TABLE 47: CANADA INFERTILITY DRUGS AND DEVICES TECHNOLOGY MARKET REVENUE BY FERTILITY TYPE, 2010 - 2017 (USD THOUSAND )
  • TABLE 48: CANADA INFERTILITY DRUGS AND DEVICES MARKET BY ARTIFICIAL INSEMINATION TECHNOLOGY, 2010 - 2017 (USD THOUSAND)
  • TABLE 49: MEXICO INFERTILITY DRUGS AND DEVICES MARKET, 2010 - 2017 (USD THOUSAND)
  • TABLE 50: MEXICO POPULATION BY DEMOGRAPHICS, 2010 - 2017 (THOUSAND)
  • TABLE 51: MEXICO MALE INFERTILITY POPULATION PREVALENCE, 2010 - 2017 (THOUSAND)
  • TABLE 52: MEXICO FEMALE INFERTILITY POPULATION PREVALENCE AND TREATED, 2010 - 2017 (THOUSAND)
  • TABLE 53: MEXICO INFERTILITY DRUGS AND DEVICES TECHNOLOGY MARKET REVENUE BY FERTILITY TYPE, 2010 - 2017 (USD THOUSAND )
  • TABLE 54: MEXICO INFERTILITY DRUGS AND DEVICES MARKET BY ARTIFICIAL INSEMINATION TECHNOLOGY, 2010 - 2017 (USD THOUSAND)
  • TABLE 55: JAPAN INFERTILITY DRUGS AND DEVICES MARKET, 2010 - 2017 (USD THOUSAND)
  • TABLE 56: JAPAN POPULATION BY DEMOGRAPHICS, 2010 - 2017 (THOUSAND)
  • TABLE 57: JAPAN MALE INFERTILITY POPULATION PREVALENCE, 2010 - 2017 (THOUSAND)
  • TABLE 58: JAPAN FEMALE INFERTILITY POPULATION PREVALENCE AND TREATED, 2010 - 2017 (MILLION)
  • TABLE 59: JAPAN INFERTILITY DRUGS AND DEVICES TECHNOLOGY MARKET REVENUE BY FERTILITY TYPE, 2010 - 2017 (USD THOUSAND )
  • TABLE 60: JAPAN INFERTILITY DRUGS AND DEVICES MARKET BY ARTIFICIAL INSEMINATION TECHNOLOGY, 2010 - 2017 (USD MILLION)
  • TABLE 61: INDIA INFERTILITY DRUGS AND DEVICES MARKET, 2010 - 2017 (USD THOUSAND)
  • TABLE 62: INDIA POPULATION BY DEMOGRAPHICS, 2010 - 2017 (THOUSAND)
  • TABLE 63: INDIA MALE INFERTILITY POPULATION PREVALENCE, 2010 - 2017 (THOUSAND
  • TABLE 64: INDIA FEMALE INFERTILITY POPULATION PREVALENCE AND TREATED, 2010 - 2017 (THOUSAND)
  • TABLE 65: INDIA INFERTILITY DRUGS AND DEVICES TECHNOLOGY MARKET REVENUE BY FERTILITY TYPE, 2010 - 2017 (USD THOUSAND )
  • TABLE 66: INDIA INFERTILITY DRUGS AND DEVICES MARKET BY ARTIFICIAL INSEMINATION TECHNOLOGY, 2010 - 2017 (USD THOUSAND)
  • TABLE 67: CHINA INFERTILITY DRUGS AND DEVICES MARKET, 2010 - 2017 (USD THOUSAND)
  • TABLE 68: CHINA POPULATION BY DEMOGRAPHICS, 2010 - 2017 (THOUSAND)
  • TABLE 69: CHINA MALE INFERTILITY POPULATION PREVALENCE, 2010 - 2017 (THOUSAND)
  • TABLE 70: CHINA FEMALE INFERTILITY POPULATION PREVALENCE AND TREATED, 2010 - 2017 (THOUSAND )
  • TABLE 71: CHINA INFERTILITY DRUGS AND DEVICES TECHNOLOGY MARKET REVENUE BY FERTILITY TYPE, 2010 - 2017 (USD THOUSAND )
  • TABLE 72: CHINA INFERTILITY DRUGS AND DEVICES MARKET BY ARTIFICIAL INSEMINATION TECHNOLOGY, 2010 - 2017 (USD THOUSAND )
  • TABLE 73: ROW INFERTILITY DRUGS AND DEVICES MARKET, 2010 - 2017 (USD THOUSAND)
  • TABLE 74: ROW FEMALE INFERTILITY POPULATION PREVALENCE AND TREATED, 2010 - 2017 (THOUSAND )
  • TABLE 75: ROW INFERTILITY DRUGS AND DEVICES MARKET BY ARTIFICIAL INSEMINATION TECHNOLOGY, 2010 - 2017 (USD THOUSAND )
  • TABLE 76: BRAZIL INFERTILITY DRUGS AND DEVICES MARKET, 2010 - 2017 (USD THOUSAND)
  • TABLE 77: BRAZIL POPULATION BY DEMOGRAPHICS, 2010 - 2017 (THOUSAND)
  • TABLE 78: BRAZIL MALE INFERTILITY POPULATION PREVALENCE, 2010 - 2017 (THOUSAND)
  • TABLE 79: BRAZIL FEMALE INFERTILITY POPULATION PREVALENCE AND TREATED, 2010 - 2017 (THOUSAND )
  • TABLE 80: BRAZIL INFERTILITY DRUGS AND DEVICES TECHNOLOGY MARKET REVENUE BY FERTILITY TYPE, 2010 - 2017 (USD THOUSAND )
  • TABLE 81: BRAZIL INFERTILITY DRUGS AND DEVICES MARKET BY ARTIFICIAL INSEMINATION TECHNOLOGY, 2010 - 2017 (USD THOUSAND )
Back to Top